Skip to main content
. 2017 Nov 3;7:14476. doi: 10.1038/s41598-017-15251-6

Figure 1.

Figure 1

HSA Peptide 40 Binding to Monoclonal Antibodies Bevacizumab, Rituximab, and Trastuzumab Kinetic Binding Parameters Determined by Biacore-SPR: A peptide library of human serum albumin (HSA) was screened via Biacore over immobilized antibodies bevacizumab, rituximab, and trastuzumab. Antibodies were immobilized via amine coupling and peptides were run at pM-uM concentration ranges. (a) HSA Peptide 40 binding curves (180 second association period, 1200 second dissociation period) against all three antibodies and the negative control antibody pembrolizumab. (b) Binding kinetics were determined via Biacore Evaluation Software analysis of SPR sensograms.